Cargando…
Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy
Non-melanoma skin cancer has recently seen an increase in prevalence, and it is estimated that this grow will continue in the coming years. In this sense, the importance of therapy effectiveness has increased, especially photodynamic therapy. Photodynamic therapy has attracted much attention as a mi...
Autores principales: | Cerro, Paulina A., Mascaraque, Marta, Gallego-Rentero, María, Almenara-Blasco, Manuel, Nicolás-Morala, Jimena, Santiago, Juan Luis, González, Salvador, Gracia-Cazaña, Tamara, Juarranz, Ángeles, Gilaberte, Yolanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634550/ https://www.ncbi.nlm.nih.gov/pubmed/36338755 http://dx.doi.org/10.3389/fonc.2022.970279 |
Ejemplares similares
-
Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy
por: Mascaraque-Checa, Marta, et al.
Publicado: (2022) -
Dermoscopic Structures Predictive of Response to Photodynamic Therapy in Basal Cell Carcinoma
por: NAVARRO-BIELSA, Alba, et al.
Publicado: (2023) -
Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer
por: Lucena, Silvia Rocío, et al.
Publicado: (2015) -
Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy
por: Gracia-Cazaña, Tamara, et al.
Publicado: (2019) -
Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells
por: Mascaraque, Marta, et al.
Publicado: (2020)